Wiley: Chemical Biology & Drug Design: Table of Contents
Discovery of novel SecA inhibitors against “Candidatus Liberibacter asiaticus” through virtual screening and biological evaluation
Chemical Biology & Drug Design, EarlyView.
Novel imidazo[2,1‐b]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation
Chemical Biology & Drug Design, EarlyView.
On the use of electronegativity and electron affinity based pseudo‐molecular field descriptors in developing correlations for quantitative structure‐activity relationship modeling of drug activities
Chemical Biology & Drug Design, EarlyView.
Synergistic interaction of N‐3‐Br‐Benzyl‐noscapine and docetaxel abrogates oncogenic potential of breast cancer cells
Chemical Biology & Drug Design, Accepted Article.
Design, synthesis, and antitumor activity evaluation of pretubulysin analogs
Chemical Biology & Drug Design, EarlyView.
Design, Synthesis, and Structure‐Activity Relationship Studies of the Anaephene Antibiotics
Chemical Biology & Drug Design, Accepted Article.
In silico prediction of drug‐induced ototoxicity using machine learning and deep learning methods
Chemical Biology & Drug Design, EarlyView.
Elucidating specificity of an allosteric inhibitor WNK476 among With‐No‐Lysine kinase isoforms using molecular dynamic simulations
Chemical Biology & Drug Design, EarlyView.
Biological evaluation the 2‐aryl‐2,3‐dihydrobenzodiazaborinin‐4(1H)‐ones as potential dual α‐glucosidase and α‐amylase inhibitors with antioxidant properties
Chemical Biology & Drug Design, EarlyView.
Synthesis, and antimalarial and antibacterial activities of marine alkaloids
Chemical Biology & Drug Design, EarlyView.
Identification of novel P2X7R antagonists by using structure‐based virtual screening and cell‐based assays
Chemical Biology & Drug Design, EarlyView.
Development and characterization of two novel 68Ga‐labelled neuropeptide Y short analogues with potential application in breast cancer imaging
Chemical Biology & Drug Design, EarlyView.
Synthesis and evolution of neuroprotective effects of oxymatrine derivatives as anti‐Alzheimer’s disease agents
Chemical Biology & Drug Design, EarlyView.
In silico identification and in vitro evaluation of a protein‐protein interaction inhibitor of Escherichia coli fatty acid biosynthesis
Chemical Biology & Drug Design, EarlyView.
Rational design of novel N‐alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents
Chemical Biology & Drug Design, Accepted Article.
Synthesis and in vitro anticancer activities of selenium N‐heterocyclic carbene compounds
Chemical Biology & Drug Design, Accepted Article.
An improved synthesis of indanocine and antiproliferative activity of 2‐benzylindanocine via microtubule destabilization
Chemical Biology & Drug Design, EarlyView.
Dithiocarbamate derivatives inhibit α‐glucosidase through an apparent allosteric site on the enzyme
Chemical Biology & Drug Design, Accepted Article.
Discovery of Novel Antibacterial Agents: Recent Developments in D‐alanyl‐D‐alanine ligase (Ddl) Inhibitors
Chemical Biology & Drug Design, Accepted Article.
SARS‐CoV‐2 first contact: spike‐ACE2 interactions in COVID‐19
Chemical Biology & Drug Design, Accepted Article.
Molecular docking‐guided synthesis of NSAID–glucosamine bioconjugates and their evaluation as COX‐1/COX‐2 inhibitors with potentially reduced gastric toxicity
Chemical Biology & Drug Design, EarlyView.
Design, synthesis and antifungal evaluation of novel mandelic acid derivatives containing a 1,3,4‐oxadiazothioether moiety
Chemical Biology & Drug Design, EarlyView.
Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy
Chemical Biology & Drug Design, EarlyView.
3‐O‐trans‐caffeoyloleanolic acid improves acute lung injury via anti‐inflammation and antioxidative stress‐involved PI3K/AKT pathway
Chemical Biology & Drug Design, EarlyView.
A Consequence of Drug Targeting of Aminoacyl‐tRNA Synthetases in Mycobacterium tuberculosis
Chemical Biology & Drug Design, Accepted Article.
Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer
Chemical Biology & Drug Design, EarlyView.
Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: strategies to the rational design of multitarget ligands
Chemical Biology & Drug Design, Accepted Article.
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptorbinding domain
Chemical Biology & Drug Design, EarlyView.
Analysis of the binding modes of the first‐ and second‐generation antiandrogens with respect to F876L mutation
Chemical Biology & Drug Design, EarlyView.
Toll‐like receptor 4 antagonist FP7 alleviates lipopolysaccharide‐induced septic shock via NF‐kB signaling pathway
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1151-1157, June 2021.
Structure‐based derivation and optimization of YAP‐like coactivator‐derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1129-1136, June 2021.
Association of sigma‐1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix–helix interactions
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1194-1209, June 2021.
Designing a leucine‐rich antibacterial nonapeptide with potent activity against mupirocin‐resistant MRSA via a structure–activity relationship study
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1185-1193, June 2021.
Synthesis of 2‐Chloro‐3‐amino indenone derivatives and their evaluation as inhibitors of DNA dealkylation repair
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1170-1184, June 2021.
Integrated molecular modeling techniques to reveal selective mechanisms of inhibitors to PI3Kδ with marketed Idelalisib
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1158-1169, June 2021.
Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1137-1150, June 2021.
Issue Information
Chemical Biology & Drug Design, Volume 97, Issue 6, Page ii-iv, June 2021.
Corrigendum
Chemical Biology & Drug Design, Volume 97, Issue 6, Page 1210-1210, June 2021.
Cover Image
Chemical Biology & Drug Design, Volume 97, Issue 6, Page i-i, June 2021.
Investigating binding tendency, stability of Sulforaphane‐N‐acetyl cysteine in the active site of histone deacetylase 2 (HDAC2) and testing its cytotoxicity against distinct cancer lines through stringent molecular dynamics, DFT and cell based assays
Chemical Biology & Drug Design, Accepted Article.
Glycoconjugates, hypothetical proteins, and post‐translational modification: Importance in host–pathogen interaction and antitubercular intervention development
Chemical Biology & Drug Design, EarlyView.
Design, synthesis and biological evaluation of N‐substituted indole‐thiazolidinedione hybrid analogues as potential pancreatic lipase inhibitors
Chemical Biology & Drug Design, EarlyView.
Benzo[a]phenazine derivatives: promising scaffolds to combat resistant Mycobacterium tuberculosis
Chemical Biology & Drug Design, Accepted Article.
Multiple Interactions between Melatonin and Non‐coding RNA in Cancer Biology
Chemical Biology & Drug Design, Accepted Article.
Synthesis, in vitro and in silico anti‐bacterial analysis of piperine and piperic ester analogues
Chemical Biology & Drug Design, EarlyView.
Synthesis and biological evaluation of tricyclic guanidine analogues of batzelladine K for antimalarial, antileishmanial, antibacterial, antifungal and anti‐HIV activities
Chemical Biology & Drug Design, Accepted Article.
Virtual and In vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against Xanthine oxidase and Cyclooxygenase‐2 for gout treatment
Chemical Biology & Drug Design, Accepted Article.
Feed Fetched by RSS Dog.